We advised Gimv, Robert Bosch Venture Capital and DFJ Esprit on the sale of all outstanding shares in GreenPeak Technologies B.V. to Qorvo. GreenPeak is a fabless semiconductor/system company and makes ZigBee semiconductor products and software technologies for Smart Home data communications and the Internet of Things.

Previously we advised GreenPeak Technologies on its 2013 equity financing round by existing shareholders comprising Gimv, Robert Bosch Venture Capital GmbH and DFJ Esprit II LP. We also advised on the company’s prior equity financing rounds and the acquisition of Ubiwave since 2007. ^*

^*  Marcel van de Vorst led these earlier transactions whilst at previous law firm.

We advised the sellers of Varitex N.V. to Lohmann & Rauscher (L&R), a leading international supplier of high quality, forward-looking medical devices and hygiene products – ranging from conventional dressing material to modern treatment and nursing systems. Varitex has been developing, producing and marketing compression stockings and other products under the brand of the same name – Varitex – on the Dutch market since its founding in 1947. In addition, Varitex also manufactures a range of private label products, for which it is already a long-term supplier of the British L&R subsidiary Activa Healthcare Ltd.

We advised BOM Capital on the sale of its shares in Acerta Pharma to Astra Zeneca. BOM Capital was one of the early investors in Acerta Pharma. Astra Zeneca has taken a 55% stake in Acerta Pharma and an option to acquire the remaining 45% interest. This sale is after BioNovion the second successful exit in biotech for BOM Capital in 2015, is the largest in the history of BOM Capital and the largest biotech deal so far in the Netherlands.

We advised BOM Capital on the sale of its shares in BioNovion to Aduro Biotech. The company, based on the Pivot Park in Oss, is the new European headquarters of Nasdaq-listed Aduro Biotech and renamed in Aduro Biotech Europe. Aduro acquired BioNovion to broaden its technological portfolio and to increase the potential of immunotherapy. BioNovion develops monoclonal antibody therapies against cancer, on the basis of their unique platform technology and expertise in the field of immune therapy of cancer.

Charles Eijsbouts advised Villebois SAS (France) in the acquisition (together with IDIA Capital Investissement, Unigrains et Carvest) of Holding Fournier SAS (France), one of the largest producers of Sauvignon Blanc in the Sancerre region.

Charles Eijsbouts assisted as interim in-house legal counsel ING Groep N.V. with respect to the sale of its South American insurance business to the Colombian Grupo Sura, the IPO of its US insurance business (Voya) and the sale of ING Direct Canada to Scotiabank.

VMware Inc. (NASDAQ: VMW) acquired all outstanding shares in the capital of Immidio BV. Immidio is a software development company for optimization of virtualization technologies in Microsoft environments. Venture capital firm Solid Ventures was one of the selling shareholders. ^*

^*  Marcel van de Vorst led this transaction for VMWare whilst at previous law firm.

We advised Prince Minerals, a leading international manufacturer of custom designed additions and mineral products, on the acquisition of Pemco International. Pemco is a manufacturer of porcelain enamel and specialty glass additives for household appliances and a range of industrial, metallurgical and glass applications. The company has factories in Belgium, Italy, USA, Argentina and Brazil. Niels Hofkes acted as coordinating counsel in this international transaction.